NI ACQUISITIONS COMPANY, LLC’s AbbVie ABBV Stock Holding History

NI ACQUISITIONS COMPANY, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$113K	Buy	+1,052	New	+$226K	0.05%	96

Other funds holding ABBV

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

NI ACQUISITIONS COMPANY, LLC's ABBV Position: Q2 2026 in Review

NI ACQUISITIONS COMPANY, LLC opened a new position in AbbVie (ABBV) in Q2 2026: 1,052 shares worth $113K. The stake represents 0.05% of the portfolio and ranks #96 among its holdings.

2,650 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

NI ACQUISITIONS COMPANY, LLC held 1,052 shares of AbbVie worth $113K as of Q2 2026.
AbbVie was a new NI ACQUISITIONS COMPANY, LLC position in Q2 2026.
AbbVie made up 0.05% of NI ACQUISITIONS COMPANY, LLC's portfolio in Q2 2026, its #96 holding.
2,650 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NI ACQUISITIONS COMPANY, LLC's 13F filing for Q2 2026, filed 5 Aug 2026.